Global Alzheimers Platform Foundation

The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimers & Parkinsons clinical trials in order to speed innovative medicines to those with or at risk of Alzheimers & Parkinsons disease. GAP is a standing, global, trial-ready platform to drive quality, efficiency, equity and innovation in Alzheimers and Parkinsons Clinical Trials, seeking to reduce clinical testing cycle times by two years or more and to achieve greater trial populations. It is doing that by building large, well-characterized trial-ready cohorts, a network...

Alzheimers,parkinsons,dementia,research,clinical trials,health care,wellness,medical,hospital,medicine,doctor,diseases,nonprofit,innovation,equality,network,volunteer,and gapnet

Global alzheimers platform foundation operates in the Hospitals and health care industry.

Global alzheimers platform foundation's revenue is 11m - 100m

Global alzheimers platform foundation has 11 - 50 employees.